Samsung Bioepis’ Autoimmune Disease Treatment ‘PYZCHIVA’ Approved in the U.S. Samsung Bioepis has announced that its biosimilar to Stelara, named ‘Pyzchiva’ (project name SB17, active ingredient…
Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease… Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease Treatment Yuhan Corporation has…
Leclaza Combination Therapy Study Published in NEJM, Raising Expectations for FDA… A study demonstrating the superior efficacy of the combination therapy of Yuhan Corporation's non-small cell lung cancer…
SK Bioscience CEO Jae-Yong Ahn: “Acquisition of Germany’s IDT Gains Us Five Crucial… Ahn Jae-Yong, CEO of SK Bioscience, highlighted the strategic importance of acquiring German contract manufacturing…
